Correlation Between Edwards Lifesciences and DexCom

Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and DexCom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and DexCom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edwards Lifesciences Corp and DexCom Inc, you can compare the effects of market volatilities on Edwards Lifesciences and DexCom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of DexCom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and DexCom.

Diversification Opportunities for Edwards Lifesciences and DexCom

0.39

Correlation Coefficient

Edwards Lifesciences  DexCom

Weak diversification

The 3 months correlation between Edwards and DexCom is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences Corp and DexCom Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DexCom Inc and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences Corp are associated (or correlated) with DexCom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DexCom Inc has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and DexCom go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and DexCom

Allowing for the 90-day total investment horizon Edwards Lifesciences Corp is expected to generate 0.76 times more return on investment than DexCom. However, Edwards Lifesciences Corp is 1.32 times less risky than DexCom. It trades about -0.03 of its potential returns per unit of risk. DexCom Inc is currently generating about -0.07 per unit of risk. If you would invest  8,595  in Edwards Lifesciences Corp on July 27, 2024 and sell it today you would lose (1,560) from holding Edwards Lifesciences Corp or give up 18.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Edwards Lifesciences Corp  vs.  DexCom Inc

Edwards Lifesciences Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Edwards Lifesciences may actually be approaching a critical reversion point that can send shares even higher in November 2024.

DexCom Inc

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Pair Trading with Edwards Lifesciences and DexCom

The main advantage of trading using opposite Edwards Lifesciences and DexCom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, DexCom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will offset losses from the drop in DexCom's long position.

The idea behind Edwards Lifesciences Corp and DexCom Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.